KalVista Pharmaceuticals Inc
NASDAQ:KALV
KalVista Pharmaceuticals Inc Stock, NASDAQ:KALV
55 Cambridge Parkway, Suite 901 East, Cambridge, Massachusetts 02142
United States of America
Phone: +1.857.999.0075
Number of Employees: 118
Description
KalVista Pharmaceuticals, Inc. is a clinical stage pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for diseases with significant unmet need. Its product candidates are inhibitors of plasma kallikrein being developed for two indications: Sebetralstat for HAE and Factor XIIa. The company was founded by T. Andrew Crockett, Edward P. Feener, and Lloyd Paul Aiello on March 26, 2004 and is headquartered in Cambridge, MA.